Early Morning With The Experts
A video series exploring biomarker testing and precision medicine in prostate cancer
Episode 1: Precision Matters
Episode 1: Precision Matters
Cora Sternberg, MD, FACP and Gordon Brown, DO, FACOS join the show to discuss how genetic mutations such as BRCA can impact prostate cancer prognosis and how precision medicine can help.
Episode 2: Mutations Uncovered
Episode 2: Mutations Uncovered
Eric Vail, MD, and Lindsey Byrne, MS, CGC reveal why it’s important to identify HRR mutations early in metastatic prostate cancer patients.
Episode 3: Talking Testing
Episode 3: Talking Testing
Cora Sternberg, MD, FACP, Gordon Brown, DO, FACOS, and Lindsey Byrne, MS, CGC return to Early Morning with the Experts to share their perspectives on biomarker testing and multidisciplinary teams.
STAY UP-TO-DATE ABOUT TESTING AND PRECISION MEDICINE IN mCRPC
Johnson & Johnson is committed to researching targeted treatment approaches to help patients with the most aggressive forms of prostate cancer, including men with BRCA mutations.1-3
Sign up for updates